One-hour oral glucose tolerance test for the postpartum reclassification of women with hyperglycemia in pregnancy
Retnakaran R, Ye C, Kramer CK, et al.
Diabetes Care. 2025:dc241848.
Leggi
Continuous glucose monitoring in type 1 diabetes, type 2 diabetes, and diabetes during pregnancy: a systematic review with meta-analysis of randomized controlled trials
Rizos EC, Markozannes G, Charitakis N, et al.
Diabetes Technol Ther. Pub. online 6 Mar 2025.
Leggi
Trajectories of sleep duration, sleep onset timing, and continuous glucose monitoring in adults
Shen L, Li BY, Gou W, et al.
JAMA Netw Open. 2025;8(3):e250114.
Leggi
Sleep characteristics and long-term risk of type 2 diabetes among women with gestational diabetes
Yin X, Bao W, Ley SH, et al.
JAMA Netw Open. 2025;8(3):e250142.
Leggi
A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
Wysham C, Bindal A, Levrat-Guillen F, et al.
Diabetes Obes Metab. Pub. online 3 Mar 2025.
Leggi
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
Sims EK, Cuthbertson D, Ferrat LA, et al.
Diabetologia. Pub. online 28 Feb 2025.
Leggi
Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials
Kanbour S, Ageeb RA, Malik RA, Abu-Raddad LJ
Lancet Diabetes Endocrinol. Pub. online 26 Feb 2025.
Leggi
A new legal standard for medical malpractice
Aaron DG, Robertson CT, King LP, Sage WM
JAMA. Pub. online 26 Feb 2025.
Leggi
REVOCA CARENZA FARMACI GLP-1 AGONISTI RECETTORIALI
Carissime Socie e Carissimi Soci, alleghiamo la recente comunicazione della Direzione Medica di Novo Nordisk che annuncia la revoca della carenza del farmaco GLP-1 agonisti recettoriali per tutti i dosaggi e senza limitazioni all’inserimento di nuovi casi di persone con diabete. Potrete visionare la lettera al seguente link. Con soddisfazione…
Leggi
Differential treatment effects on β-cell function using model-based parameters in type 2 diabetes: results from the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE)
Utzschneider KM, Tripputi M, Butera NM, et al.
Diabetes Care. 2025:dc242419.
Leggi